# Zoetis Inc. (ZTS): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Zoetis Inc. (ZTS) is 75/100, ranked against 24,000+ stocks in 35 markets (Quality 77, Value 66, Momentum 27, each scored against its sector).

- StockRank: 75/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 77, Value 66, Momentum 27: each a 0-100 percentile within the stock's sector.
- Position: #6,773 overall, #724 in Healthcare.
- Listing: United States, NYQ; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 75.65 USD on 12 Oct 2026.
- Insider filings, last 180 days: directors bought USD 886K.
- Buybacks, last 180 days: the company bought back USD 2.0B on 2 days.

Source: https://moatmap.ai/stock/ZTS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker